108 related articles for article (PubMed ID: 17395421)
1. Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells.
Naruse T; Nishida Y; Ishiguro N
Biomed Pharmacother; 2007 Jul; 61(6):338-46. PubMed ID: 17395421
[TBL] [Abstract][Full Text] [Related]
2. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.
Naruse T; Nishida Y; Hosono K; Ishiguro N
Carcinogenesis; 2006 Mar; 27(3):584-92. PubMed ID: 16219634
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
Wolfesberger B; Walter I; Hoelzl C; Thalhammer JG; Egerbacher M
Res Vet Sci; 2006 Jun; 80(3):308-16. PubMed ID: 16182328
[TBL] [Abstract][Full Text] [Related]
4. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
5. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P
Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
8. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line.
Liu SY; Song SX; Lin L; Liu X
Chemotherapy; 2010; 56(2):101-7. PubMed ID: 20357441
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells.
Wolfesberger B; Hoelzl C; Walter I; Reider GA; Fertl G; Thalhammer JG; Skalicky M; Egerbacher M
J Vet Pharmacol Ther; 2006 Feb; 29(1):15-23. PubMed ID: 16420297
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
12. Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress.
Zhong J; Dong X; Xiu P; Wang F; Liu J; Wei H; Xu Z; Liu F; Li T; Li J
Cell Prolif; 2015 Dec; 48(6):691-704. PubMed ID: 26481188
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells.
Bijnsdorp IV; van den Berg J; Kuipers GK; Wedekind LE; Slotman BJ; van Rijn J; Lafleur MV; Sminia P
J Neurooncol; 2007 Oct; 85(1):25-31. PubMed ID: 17447009
[TBL] [Abstract][Full Text] [Related]
14. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.
Zhang C; Zhao Y; Zeng B
Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
Sun J; Fu ZM; Fang CQ; Li JH
Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
[TBL] [Abstract][Full Text] [Related]
17. The in vitro effects of piroxicam and meloxicam on canine cell lines.
Knottenbelt C; Chambers G; Gault E; Argyle DJ
J Small Anim Pract; 2006 Jan; 47(1):14-20. PubMed ID: 16417605
[TBL] [Abstract][Full Text] [Related]
18. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
[TBL] [Abstract][Full Text] [Related]
19. Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways.
Dong X; Li R; Xiu P; Dong X; Xu Z; Zhai B; Liu F; Jiang H; Sun X; Li J; Qiao H
PLoS One; 2014; 9(3):e92864. PubMed ID: 24675684
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of SB injection in canine osteosarcoma and melanoma cell lines.
Kweon K; Ahn JO; Song WJ; Li Q; Lee BY; Chae HK; Youn HY
In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):7-16. PubMed ID: 30382494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
